Press releases

Press release

March 2, 2026

Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®

Read more

Press release

February 26, 2026

Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Read more

Press release

February 24, 2026

Lantheus to Present at March 2026 Investor Conferences

Read more

Press release

February 12, 2026

Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

Read more

Press release

January 2, 2026

Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies

Read more

Press release

November 24, 2025

Lantheus to Present Florbetaben F 18 Data at CTAD 2025

Read more

Press release

November 6, 2025

Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update

Read more

Press release

November 6, 2025

Lantheus Announces Leadership Transition Plan

Read more

Press release

October 30, 2025

Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

Read more

For access to press releases before 2022 and full-text search capabilities, please visit our investor site.